🔧 Filters
Try: author name · keyword phrase · DOI
Original Article
Background: Chemotherapy remains an important treatment for advanced non-small cell lung cancer (NSCLC), but it is associated with hematological and non-hematological toxicities and may affect antitum
non-small cell lung cancerCurcumaChanna striata extractCD8+ T cellshematological toxicitynon-hematological toxicity
Original Article
Background: Transforming growth factor-beta (TGF-β) is a key immunosuppressive cytokine involved in tumor progression, immune evasion, and therapeutic resistance in non–small cell lung cancer (NSCLC).
Nonsmall cell lung cancer AHCC Transforming growth factor-beta TGF- Immunomodulation Platinum-based chemotherapy
Original Article
Background: Chemotherapy may induce immunosuppression and systemic inflammation in patients with non-small cell lung cancer (NSCLC). Curcumin and Channa striata have immunomodulatory and anti-inflamma
non-small cell lung cancerimmunonutritioncurcuminChanna striataCD4+ T cellsneutrophil-to-lymphocyte ratio.
Original Article
Background: Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy with survival rates approaching 90%. Hypertension is an increasingly recognized complication during induction che
Acute lymphoblastic leukemiaHypertensionInduction chemotherapyPediatric oncology.
Original Article
Background: Lung cancer remains the leading cause of cancer-related mortality worldwide, with most cases diagnosed at advanced stages. In non–small cell lung cancer (NSCLC), inflammation plays a criti
nonsmall cell lung cancer interferon-gamma AHCC chemotherapy quality of life
Original Article
Background: Capecitabine–oxaliplatin (CAPOX) is a commonly used chemotherapy regimen in gastric and colorectal malignancies. Although its efficacy has been well established in randomized trials, real-
CAPOXgastric cancerrectal cancerchemotherapy toxicitytreatment compliance
Original Article
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting toxicity of neurotoxic chemotherapy that significantly impairs quality of life (QoL) and functional status. Des
Chemotherapy-induced peripheral neuropathyCIPNtaxanesoxaliplatinbortezomibquality of life
Systematic Review
Objective: To evaluate the efficacy, safety, and clinical impact of blinatumomab across the treatment continuum of B-cell acute lymphoblastic leukemia. Design: Systematic evidence synthesis of randomi
Acute Lymphoblastic LeukemiaBlinatumomabImmunotherapyMinimal Residual DiseaseSurvival Analysis
Case Report
Objective: To describe an exceptionally rare occurrence of chronic myeloid leukemia developing in the setting of relapsed refractory classical Hodgkin lymphoma following multi line chemotherapy, and t
ChemotherapyCombinationHodgkin DiseaseLeukemiaMyelogenousChronic
Original Article
The breast is a rare location for the development of a malignant lymphoma with the incidence of Primary breast lymphoma (PBL) being less than 0.5% of all breast malignancies and 2% of all extranodal l
Breast LymphomaExtranodalDLBCLImmunohistochemistryChemotherapy
11
Surgical resection remains the cornerstone of curative treatment for solid tumors. However, the same biological processes that the body mobilizes to heal the surgical wound may paradoxically favor the
wound healing paradoxtumor-cell entrapmentperitoneal metastasissurgical oncologyHIPECPIPAC
Review Article
Objective: To evaluate the clinical efficacy and translational relevance of Claudin-18.2 (CLDN18.2)–targeted therapy in advanced gastric and gastro-oesophageal junction adenocarcinoma, and to assess i
Claudin-18.2 (CLDN18.2)Gastric cancerGastro-oesophageal junction adenocarcinomaPrecision oncologyZolbetuximab.
Original Article
Background: Background: High-grade salivary gland carcinomas (SGCs) often lack architectural hallmarks, leading to their classification as "Adenocarcinoma, Not Otherwise Specified" (ANOS). This "waste
Salivary Duct Carcinoma AdenocarcinomaNOS Androgen Receptor Precision Oncology Immunohistochemistry India
Review Article
Background: The perioperative period is a "vulnerable window" where surgical stress and anesthetic choice may influence long-term oncological prognosis. This review evaluates the impact of anesthetic
Breast cancer surgeryAnesthetic modalitiesOncological outcomesImmune modulation
Original Article
Background: Anemia is a frequent comorbidity in women with gynecological malignancies, adversely affecting tolerance to surgery, chemotherapy, and radiotherapy. Despite its clinical relevance, Indian
anemiagynecologic cancercervix carcinomaovarian cancerprevalence